CD276 and cancer: This rare expression pattern makes B7-H3 an optimal prognostic biomarker for cancer diagnosis and therapy and a predictive biomarker, given that its persisting expression is often associated with poor prognosis (Fan et al., 2023; He et al., 2025; Tolmac et al., 2025).